Third Point takes stake in Cano Health, pushes for company sale
Reuters
Published Mar 09, 2022 10:13AM ET
Updated Mar 09, 2022 04:02PM ET
By Svea Herbst-Bayliss
BOSTON (Reuters) -Hedge fund Third Point LLC is pushing Cano Health to put itself up for sale because the senior-care facility operator's stock price has tumbled since it went public with a blank check company.
The New York-based firm, run by billionaire investor Daniel Loeb, said in a regulatory filing that it now owns 6.4% of the Miami-based company, making it the third-largest investor.
Third Point, which invests $18 billion, spent $106 million to buy 11.5 million shares, the filing said.
Loeb, who has run activist campaigns at Baxter International (NYSE:BAX) and Campbell Soup Company (NYSE:CPB) and recently pushed Intel Corp (NASDAQ:INTC) to make changes, said his firm is currently not looking for board seats. The filing said the firm has "confidence" in the company's strategy and management team.
But that could change, the filing said, if the company fails to address the "value gap" between its share price and intrinsic value of the company.
Cano's sluggish stock price is related to the fact that investors have "a largely unfavorable view of companies taken public through special purpose acquisition vehicles", Loeb wrote. He urged the company to hire bankers and lawyers to review strategic alternatives and said "this strategic review should focus on a sale."
Cano Health closed its merger with investor Barry Sternlicht's special purpose acquisition company in June and its stock price lost more than half of its value. On Wednesday the stock price surged 40% on news Third Point was involved, valuing the company at $3 billion.
Cano said in a statement that it is "successfully executing its strategy" and that the business has strong momentum, "as demonstrated by our 115% year-over-year membership growth in 2021 and continued growth into 2022." The company, which operates primary care medical centers in eight U.S. states and Puerto Rico, also said it welcomes shareholder perspectives.
Third Point participated in a private placement alongside Sternlicht and Fidelity Management & Research Company and BlackRock (NYSE:BLK), according to a statement made when the deal was announced.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.